Ultragenyx Gets Commercial Feet Wet With Mepsevii Launch In Sly Syndrome
Commercial opportunity for Mepsevii is small, but launch paves way for company's second product burosumab, following on its heels.
Commercial opportunity for Mepsevii is small, but launch paves way for company's second product burosumab, following on its heels.